Sofinnova Ventures
Latest statistics and disclosures from Sofinnova Investments's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Karuna Therapeutics Ord, NTRA, AZN, MRK, ASND, and represent 38.39% of Sofinnova Investments's stock portfolio.
- Added to shares of these 10 stocks: Rayzebio (+$54M), ELAN (+$41M), IWM (+$40M), SNY (+$37M), KVUE (+$36M), SPY (+$21M), CYTK (+$21M), MRK (+$21M), ImmunoGen (+$19M), ARGX (+$19M).
- Started 19 new stock positions in IMVT, SRPT, IMTXW, IKNA, SYBX, Shockwave Med, ALKS, GPCR, SNY, ELAN. CRSP, MLTX, IWM, SPY, Cymabay Therapeutics, Powershares Qqq Etf Put Opt 01/19 154.0 put, Rayzebio, SYK, KVUE.
- Reduced shares in these 10 stocks: , BSX (-$33M), Reata Pharmaceuticals Inc Cl A (-$33M), AZN (-$23M), VIR (-$19M), EXEL (-$18M), BAX (-$17M), RVMD (-$14M), PTCT (-$11M), ISRG (-$8.2M).
- Sold out of its positions in ALLK, BAX, BSX, FGEN, PTCT, Reata Pharmaceuticals Inc Cl A, RVMD, Synlogic, VRTX, VIR.
- Sofinnova Investments was a net buyer of stock by $250M.
- Sofinnova Investments has $1.6B in assets under management (AUM), dropping by 3.83%.
- Central Index Key (CIK): 0001631134
Tip: Access up to 7 years of quarterly data
Positions held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 57 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 14.7 | $234M | 1.4M | 169.09 |
|
|
| Natera (NTRA) | 8.7 | $137M | 3.1M | 44.25 |
|
|
| AstraZeneca Sponsored Adr (AZN) | 5.8 | $92M | -19% | 1.4M | 67.72 |
|
| Merck & Co (MRK) | 4.7 | $75M | +38% | 728k | 102.95 |
|
| Ascendis Pharma A/S Sponsored Adr (ASND) | 4.5 | $71M | 754k | 93.64 |
|
|
| Rayzebio | 3.4 | $54M | NEW | 2.4M | 22.20 |
|
| Dex (DXCM) | 3.2 | $51M | +48% | 550k | 93.30 |
|
| Aerovate Therapeutics (AVTE) | 3.2 | $51M | 3.8M | 13.57 |
|
|
| Intuitive Surgical (ISRG) | 3.2 | $51M | -13% | 173k | 292.29 |
|
| Vera Therapeutics Cl A (VERA) | 3.0 | $48M | 3.5M | 13.71 |
|
|
| Cytokinetics (CYTK) | 2.9 | $46M | +85% | 1.6M | 29.46 |
|
| Elanco Animal Health (ELAN) | 2.6 | $41M | NEW | 3.6M | 11.24 |
|
| IShares TR Russell 2000 Etf Put Option (IWM) | 2.5 | $40M | NEW | 225k | 176.74 |
|
| argenx SE Sponsored Adr (ARGX) | 2.4 | $38M | +95% | 78k | 491.63 |
|
| Exelixis Put Option (EXEL) | 2.4 | $38M | -31% | 1.7M | 21.85 |
|
| Immatics NV SHS (IMTX) | 2.4 | $38M | +6% | 3.3M | 11.58 |
|
| Sanofi Sponsored Adr (SNY) | 2.4 | $37M | NEW | 695k | 53.64 |
|
| Kenvue (KVUE) | 2.3 | $36M | NEW | 1.8M | 20.08 |
|
| IDEXX Laboratories (IDXX) | 2.1 | $34M | +10% | 78k | 437.27 |
|
| ImmunoGen | 2.0 | $33M | +147% | 2.0M | 15.87 |
|
| Syndax Pharmaceuticals Put Option (SNDX) | 1.8 | $29M | +25% | 2.0M | 14.52 |
|
| Ideaya Biosciences (IDYA) | 1.8 | $28M | +56% | 1.0M | 26.98 |
|
| Zentalis Pharmaceuticals (ZNTL) | 1.5 | $24M | +46% | 1.2M | 20.06 |
|
| SPDR S&P 500 ETF Trust Tr Unit Put Option (SPY) | 1.3 | $21M | NEW | 50k | 427.48 |
|
| Replimune Group Put Option (REPL) | 1.2 | $18M | +205% | 1.1M | 17.11 |
|
| Inozyme Pharma (INZY) | 1.1 | $18M | +17% | 4.3M | 4.20 |
|
| Invesco QQQ TR Unit Ser 1 | 1.1 | $18M | NEW | 50k | 358.27 |
|
| Celldex Therapeutics (CLDX) | 1.1 | $17M | +215% | 624k | 27.52 |
|
| Agenus Call Option (AGEN) | 1.1 | $17M | +204% | 15M | 1.13 |
|
| MoonLake Immunotherapeutics Class A Ord (MLTX) | 1.1 | $17M | NEW | 293k | 57.00 |
|
| Shockwave Med | 1.0 | $16M | NEW | 81k | 199.10 |
|
| Alkermes SHS (ALKS) | 0.9 | $15M | NEW | 538k | 28.01 |
|
| Inhibrx (INBX) | 0.9 | $14M | -25% | 743k | 18.35 |
|
| Y Mabs Therapeutics (YMAB) | 0.8 | $12M | 2.2M | 5.45 |
|
|
| Marinus Pharmaceuticals Call Option (MRNS) | 0.7 | $11M | +12% | 1.3M | 8.05 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.6 | $10M | NEW | 202k | 50.42 |
|
| CRISPR Therapeutics Namen Akt Put Option (CRSP) | 0.6 | $9.1M | NEW | 200k | 45.39 |
|
| Geron Corporation (GERN) | 0.5 | $7.8M | -31% | 3.7M | 2.12 |
|
| Sarepta Therapeutics Call Option (SRPT) | 0.4 | $6.2M | NEW | 51k | 121.22 |
|
| Dyne Therapeutics (DYN) | 0.4 | $6.1M | +55% | 685k | 8.96 |
|
| Axsome Therapeutics (AXSM) | 0.4 | $5.6M | -55% | 80k | 69.89 |
|
| Immunovant (IMVT) | 0.3 | $5.4M | NEW | 140k | 38.39 |
|
| Nextcure (NXTC) | 0.2 | $3.4M | 2.7M | 1.29 |
|
|
| Nucana Sponsored Adr (NCNA) | 0.2 | $3.4M | 5.6M | 0.61 |
|
|
| Bolt Biotherapeutics (BOLT) | 0.2 | $2.9M | 2.8M | 1.04 |
|
|
| Nucana Common Shares | 0.1 | $1.5M | 2.4M | 0.61 |
|
|
| Immatics NV *w Exp 07/01/2025 (IMTXW) | 0.1 | $1.1M | NEW | 319k | 3.54 |
|
| Stryker Corporation (SYK) | 0.1 | $896k | NEW | 3.3k | 273.27 |
|
| Pds Biotechnology Ord (PDSB) | 0.0 | $720k | 143k | 5.05 |
|
|
| Savara (SVRA) | 0.0 | $597k | +64% | 158k | 3.78 |
|
| Galera Therapeutics (GRTX) | 0.0 | $540k | 3.1M | 0.18 |
|
|
| Ikena Oncology (IKNA) | 0.0 | $501k | NEW | 116k | 4.33 |
|
| Fusion Pharmaceuticals (FUSN) | 0.0 | $305k | 117k | 2.60 |
|
|
| Mirum Pharmaceuticals (MIRM) | 0.0 | $287k | 9.1k | 31.60 |
|
|
| Cymabay Therapeutics Put Option | 0.0 | $165k | NEW | 11k | 14.91 |
|
| Spruce Biosciences (SPRB) | 0.0 | $131k | 58k | 2.26 |
|
|
| Synlogic (SYBX) | 0.0 | $108k | NEW | 38k | 2.81 |
|
Past Filings by Sofinnova Investments
SEC 13F filings are viewable for Sofinnova Investments going back to 2018
- Sofinnova Investments 2023 Q3 filed Nov. 14, 2023
- Sofinnova Investments 2023 Q2 filed Aug. 14, 2023
- Sofinnova Investments 2023 Q1 filed May 11, 2023
- Sofinnova Investments 2022 Q4 filed Feb. 14, 2023
- Sofinnova Investments 2022 Q3 filed Nov. 8, 2022
- Sofinnova Investments 2022 Q2 filed Aug. 15, 2022
- Sofinnova Investments 2022 Q1 filed May 16, 2022
- Sofinnova Investments 2021 Q4 filed Feb. 14, 2022
- Sofinnova Investments 2021 Q3 filed Nov. 15, 2021
- Sofinnova Investments 2021 Q2 filed Aug. 16, 2021
- Sofinnova Investments 2021 Q1 filed May 14, 2021
- Sofinnova Investments 2020 Q4 filed Feb. 16, 2021
- Sofinnova Investments 2020 Q3 filed Nov. 13, 2020
- Sofinnova Investments 2020 Q2 filed Aug. 13, 2020
- Sofinnova Investments 2020 Q1 filed May 13, 2020
- Sofinnova Investments 2019 Q4 filed Feb. 14, 2020